Allergan reports continued focus on eye care business

Allergan’s commitment to its eye care business includes advancing new products for both the front and back of the eye, CEO Brent Saunders said at the 37th annual J.P. Morgan Healthcare Conference in San Francisco.
The company’s business plan included a $400 million cost reduction program at the beginning of 2018 and a decision to narrow its focus to four key areas: eye care, medical aesthetics, central nervous system and gastrointestinal.
“This summer we undertook an extensive review of our strategy and made a very clear decision that we would (Read more...)

Full Story →